Ryan DH - Search Results

1

Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study.

Ryan DH, Kopecky KJ, Head D, Grever MR, Shiaer SM, Lipschitz DA, Hynes HE, Vial RH, Veith RW, Gumbart CH. Ryan DH, et al. Am J Clin Oncol. 1992 Feb;15(1):69-75. doi: 10.1097/00000421-199202000-00013. Am J Clin Oncol. 1992. PMID: 1550082 Clinical Trial.

2

Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.

Ryan DH, Kopecky KJ, Head D, Gumbart CN, Grever MR, Karanes C, Weick JK, Coltman CA Jr. Ryan DH, et al. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):713-6. Cancer Treat Rep. 1987. PMID: 3475171

3

Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.

Ryan DH, Bickers JN, Vial RH, Hussein K, Bottomley R, Hewlett JS, Wilson HE, Stuckey WJ. Ryan DH, et al. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):869-72. Cancer Treat Rep. 1980. PMID: 7448824

4

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M, et al. Head D, et al. Blood. 1995 Sep 1;86(5):1717-28. Blood. 1995. PMID: 7655004 Free article.

5

Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group Study.

Morrison FS, Benjamin R, Amare M, Costanzi JJ, Hussein K, Ryan DH, Balcerzak S, Pendleton OJ. Morrison FS, et al. Among authors: ryan dh. Am J Clin Oncol. 1982 Dec;5(6):645-8. doi: 10.1097/00000421-198212000-00013. Am J Clin Oncol. 1982. PMID: 7165008

6

A noninvasive technique for monitoring response to chemotherapy in human acute leukemia.

Posey LE, Rainey J, Vial R, Ryan D, Bickers JH, Morgan LR Jr, Samuels MS, Hull EW. Posey LE, et al. Cancer. 1979 Sep;44(3):873-80. doi: 10.1002/1097-0142(197909)44:3<873::aid-cncr2820440313>3.0.co;2-t. Cancer. 1979. PMID: 38900

7

Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.

Morgan LR, Posey LE, Rainey J, Bickers J, Ryan D, Vial R, Hull EW. Morgan LR, et al. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):693-5. Cancer Treat Rep. 1981. PMID: 6265084 No abstract available.

8

Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.

Ahmann FR, Meyskens FL Jr, Jones SE, Bukowski RM, Saiers JH, Ryan DH, Costanzi J, Vaughn CB, Coltman CA Jr. Ahmann FR, et al. Among authors: ryan dh. Cancer Treat Rep. 1983 Jul-Aug;67(7-8):697-700. Cancer Treat Rep. 1983. PMID: 6688199

9

Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.

Weick JK, Jones SE, Ryan DH. Weick JK, et al. Among authors: ryan dh. Cancer Treat Rep. 1983 May;67(5):489-92. Cancer Treat Rep. 1983. PMID: 6687839

10

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study.

Ard JD, Ryan DH, O'Neil PM, Kushner RF, Wyatt HR, Bays HE, Greenway FL, Jakicic JM, Leonard S, Kenan Y, Ganon-Elazar E, Wadden TA. Ard JD, et al. Among authors: ryan dh. Obesity (Silver Spring). 2025 Feb 4. doi: 10.1002/oby.24240. Online ahead of print. Obesity (Silver Spring). 2025. PMID: 39904726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters